SectorMetals and Mining
Established Date--
Listing Date19/04/2024
ExchangeAmerican Stock Exchange
Full-time Employees66
Fiscal Year Ends31/12
Security TypeCommon stock
Office address7 Times Square, Suite 2503, New York, NY 10036
Business
IntroductionSolaris Resources Inc. was founded in Canada. Solaris is a late-stage clinical biopharmaceutical company focused on developing new treatments for a wide range of cancer indications. The company's product candidates currently include galinpepimuts (GPS), a peptide immunotherapy targeting the Wilms tumor 1 (WT1) antigen, and SLS009 (formerly known as GFH009), a highly selective small molecule cyclin-dependent kinase 9 (CDK9) inhibitor.
